Teardrop Effervescent Tablet, Rapid Dissolution, Oral Drug Delivery
Summary
USPTO published patent application US20260096993A1 for a teardrop-shaped effervescent tablet designed for rapid dissolution oral drug delivery. The application (No. 18909065) was filed on October 8, 2024 and published April 9, 2026. Inventors Philip Mackenzie and Dan Aziz disclose a tablet with asymmetric geometry and cupped surfaces engineered to accelerate dissolution rates and improve bioavailability of active ingredients.
What changed
USPTO published patent application US20260096993A1 disclosing a teardrop-shaped effervescent tablet with asymmetric geometry for oral drug delivery. The tablet design features two asymmetric eccentric circles within a reference circle, cupped top and bottom surfaces, and blended land where sidewalls meet surfaces, optimized for rapid dissolution.
Affected parties in the pharmaceutical and nutraceutical industries should monitor this application for potential future licensing opportunities or competitive landscape considerations. The invention addresses delivery of difficult-to-digest medications or large-dose nutrients requiring enhanced bioavailability, representing a design advancement in effervescent tablet technology.
What to do next
- Monitor for updates
Archived snapshot
Apr 13, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Effervescent tablet
Application US20260096993A1 Kind: A1 Apr 09, 2026
Inventors
Philip Mackenzie, Dan Aziz
Abstract
Disclosed is a teardrop shaped tablet defined in a top or bottom plan by two asymmetric and eccentric circles within a reference circle. Top and bottom surfaces are cupped and the sidewalls are upright. The sidewalls and top surfaces meet with a blended land. This design allows the tablet to be inserted into the vessel, enhancing its ability to dissolve quickly and efficiently. The overall thickness, curvature, and other geometric properties are optimized to ensure rapid dissolution, making the tablet suitable for delivering nutrients or medications that are difficult to digest or require large doses. The invention aims to improve the bioavailability of active ingredients, making them more effective for certain nutritional or medical needs, and represents a significant advancement in the field of effervescent tablets.
CPC Classifications
A61K 9/2072 A61K 9/0007
Filing Date
2024-10-08
Application No.
18909065
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.